3 results
Approved WMOCompleted
The primary objective of this study is to compare the overall survival (OS) distributions between LY2157299 monohydrate plus lomustine therapy with lomustine plus placebo therapy (control arm), in patients who have relapsed or have progressive GB…
Approved WMOCompleted
To validate 18F-Flutemetamol PET in the evaluation of plaque vulnerability.
Approved WMOPending
• To evaluate the efficacy of treatment• To evaluate the safety of treatment